C12Y 207/0706
2-c-methyl-d-erythritol 4-phosphate cytidylyltransferase
Official title: 2-C-Methyl-D-erythritol 4-phosphate cytidylyltransferase (2.7.7.60)
C12Y207/0706 (2-c-methyl-d-erythritol 4-phosphate cytidylyltransferase) appears on 4 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 8
- Assignees
- 7
- Inventors
- 16
- Latest grant
- 29 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Microbial fermentation for the production of terpenes29 Apr 2025US 12,286,660 B2LanzaTech, Inc.
- Metabolic engineering of E. coli for the biosynthesis of cannabinoid3 Sep 2024US 12,077,802 B2Inmed Pharmaceuticals Inc.
- Microbial fermentation for the production of terpenes4 Oct 2022US 11,459,589 B2LanzaTech NZ, Inc.
- Microbial fermentation for the production of terpenes9 Feb 2021US 10,913,958 B2Lanzatech New Zealand Limited
- Microbial fermentation for the production of terpenes19 Jan 2023US 2023/0013524 A1LanzaTech NZ, Inc.
- Compositions and methods for biosynthesis of terpenoids or cannabinoids in a heterologous system2 Jun 2022US 2022/0170056 A1Inmed Pharmaceuticals Inc.
- Microbial fermentation for the production of terpenes4 Mar 2021US 2021/0062229 A1Lanzatech New Zealand Limited
- Metabolic engineering of e. coli for the biosynthesis of cannabinoid products17 Sep 2020US 2020/0291434 A1Inmed Pharmaceuticals Inc.
- Microbial fermentation for the production of terpenes24 May 2018US 2018/0142265 A1Lanzatech New Zealand Limited
Most cited
By later US patents